INFLAMMATORY BREAST CANCER
Clinical trials for INFLAMMATORY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY BREAST CANCER trials appear
Sign up with your email to follow new studies for INFLAMMATORY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against aggressive breast cancer
Disease control CompletedThis study tested a combination of chemotherapy (paclitaxel) and two targeted antibodies (trastuzumab and pertuzumab) given before mastectomy to 23 women with HER2-positive inflammatory breast cancer. The goal was to see if the treatment could wipe out all cancer in the breast an…
Matched conditions: INFLAMMATORY BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Home sweet home? breast cancer patients may prefer At-Home drug infusions
Symptom relief CompletedThis study looked at whether people with early or locally advanced HER2-positive breast cancer prefer receiving their medication (a combination of pertuzumab and trastuzumab) at home versus in the hospital. About 346 participants were randomly assigned to receive the drug at home…
Matched conditions: INFLAMMATORY BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC